The Wire · №471 · 16 October 2026

International Cannabis Weekly

One curated brief a week on the developments that move the market — 35 stories this week across 6 regions, every one sourced and placed where it happened.

1. Netherlands: Bedrocan bankruptcy leaves medical cannabis batches frozen in storage (Business of Cannabis)
2. United States: Curaleaf's takeover battle shifts in Aurora's favour (Business of Cannabis)
3. Ukraine: Ukraine's health ministry reports first cancer patient to receive cannabis-based medicine (Newsweed)
4. France: French senators table bill creating seed-to-sale register for CBD flower (Newsweed)
5. Poland: INCB cuts Poland's 2026 medical cannabis estimate by 9.1% to 19.03 tonnes (faktykonopne.pl)
6. United Kingdom: Jersey tightens medicinal cannabis prescribing rules after coroner links prescription to fatal fire (BBC)
7. Netherlands: Cronos Group completes €57.5m acquisition of CanAdelaar, largest grower in Dutch cannabis pilot (Cannabis Industrie)
8. Portugal: Tilray Medical authorised to run EU-GMP batch release testing in-house at Cantanhede (CannaReporter)
9. France: France's final medical cannabis decree reaches Conseil d'État, first prescriptions possible in 2027 (Business of Cannabis)
10. United States: DEA's chief judge keeps rescheduling hearing stayed, orders agency reply by 21 October (Cannabis Business Times)
11. United States: Federal lawyers and rescheduling challengers agree DC Circuit briefing schedule ending mid-February (Marijuana Moment)
12. United States: South Dakota's attorney general says federal rescheduling has negligible impact on medical programme (Marijuana Moment)
13. United States: Ohio's new potency and package caps take effect, pulling high-strength vapes off shelves (MJBizDaily)
14. United States: Marijuana Policy Project lobbies Congress to replace looming hemp THC ban with age-gated regulation (Cannabis Business Times)
15. United States: Minnesota's $200m hemp THC sector reports lost orders and layoffs ahead of 11 December federal ban (fox9.com)
16. United States: Illinois cannabis tax receipts fall to $456m in fiscal 2026 as sales drop to about $1.5bn (chicago.suntimes.com)
17. United States: Puerto Rico's Ley 204-2026 removes job protections for medical cannabis patients in transport (El Planteo)
18. Canada: Aurora Cannabis rejects Curaleaf's revised US$5 bid and signs standstill agreements with multiple parties (Newswire)
19. Canada: Health Canada's 2025-26 compliance data show 29 non-compliance reports from 673 inspections (themarijuanaherald.com)
20. Canada: Canopy Growth's Smiths Falls site wins EU-GMP certification from Tübingen regulator (biopharmawatch.com)
21. Canada: Organigram completes Sanity Group integration, targeting up to C$10m annualised savings by fiscal 2028 (Mugglehead)
22. Canada: Cantourage becomes exclusive European distributor for Quebec's Green Karat after EU-GMP win (Newswire)
23. Canada: High Tide buys Chestermere, Alberta store for C$670,000, taking Canna Cabana network to 234 locations (Cannabis Business Times)
24. Brazil: Brazil's Anvisa authorises two new presentations of Fiocruz's state-made 200mg/mL cannabidiol solution (CannaReporter)
25. Brazil: Anvisa data show Brazilian patients filed 114,708 cannabis import requests in H1 2026, up 51% in two years (Sechat)
26. Brazil: Brazil's Ease Labs opens talks with partners in Germany, Poland and England to export medical cannabis (Sechat)
27. Morocco: Morocco's cannabis regulator ANRAC withdraws 1,490 licences, including about 1,300 held by farmers (hespress.com)
28. South Africa: South Africa's SAHPRA has issued almost no Section 21 medical cannabis approvals since July, operators say (Cannabiz Africa)
29. Australia: Cannabis Council Australia convenes first working party to shape TGA's TGO 93 standards overhaul (Cannabiz)
30. Australia: Montu, Australia's largest medicinal cannabis group, tells staff substantial number of jobs will go (Cannabiz)
31. Australia: BLS Pharmaceuticals posts record Q1 FY27 revenue of A$26.7m, up 23% on the quarter (asx.api.markitdigital.com)
32. Australia: Vitura Health lifts Q1 FY27 revenue by 4.8% and EBITDA by 197.5% as dispensing volumes rise 19% (asx.api.markitdigital.com)

• 9Europe
• 10United States
• 6Canada
• 3LATAM & Caribbean
• 2Africa & Middle East
• 4Oceania